Skip to main content

Advertisement

SpringerLink
Log in

Contrast-induced nephropathy: pathogenesis and prevention

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Contrast-induced nephropathy (CIN) is the third most common cause of acute kidney injury in hospitalized patients. Diagnostic and interventional cardiovascular procedures generate nearly half the cases. Elderly patients and those with chronic kidney disease, diabetes, and cardiovascular disease are at greatest risk. Procedure-related risk factors include large volumes of contrast and agents with a high osmolality. Renal medullary ischemia arising from an imbalance of local vasoconstrictive and vasodilatory influences coupled with increased demand for oxygen-driven sodium transport may be the key to its pathogenesis. Contrast agents may also have a direct cytotoxic effect that operates through the generation of reactive oxygen species. Pre- and post-procedure administration of normal saline, isotonic sodium bicarbonate, N-acetylcysteine, and a variety of other pharmacologic agents have been used to prevent or mitigate CIN. While normal saline is generally accepted as protective against CIN, uncertainty still surrounds the role of sodium bicarbonate and N-acetylcysteine. Dialytic therapies before, during, and after exposure to contrast have been tested with mixed results. Logistical and economic disincentives argue against these modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2006) Heart disease and stroke statistics—2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85–e151

    Google Scholar 

  2. Persson PB (2005) Editorial: contrast medium-induced nephropathy. Nephrol Dial Transplant 20[Suppl 1]:i1

    PubMed  Google Scholar 

  3. Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, Palevsky PM (2006) Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17:2871–2877

    CAS  PubMed  Google Scholar 

  4. Liss P, Persson PB, Hansell P, Lagerqvist B (2006) Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 70:1811–1817

    CAS  PubMed  Google Scholar 

  5. McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375

    CAS  PubMed  Google Scholar 

  6. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    PubMed  Google Scholar 

  7. Solomon R, Barrett B (2006) Follow-up of patients with contrast-induced nephropathy. Kidney Int Suppl:S46–50

  8. Katholi RE, Taylor GJ, Woods WT, Womack KA, Katholi CR, McCann WP, Moses HW, Dove JT, Mikell FL, Woodruff RC, Miller BD, Schneider JA (1993) Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings. Radiology 186:183–187

    CAS  PubMed  Google Scholar 

  9. Shah SH, Mehta RL (2006) Acute kidney injury in critical care: time for a paradigm shift? Curr Opin Nephrol Hypertens 15:561–565

    PubMed  Google Scholar 

  10. Hoste EA, Kellum JA (2006) Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Crit Care 12:531–537

    PubMed  Google Scholar 

  11. Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, Riesen W, Wuthrich RP (2004) Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 61:98–102

    CAS  PubMed  Google Scholar 

  12. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P (2007) NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089–2095

    PubMed  Google Scholar 

  13. Chertow GM (1997) On the design and analysis of multicenter trials in acute renal failure. Am J Kidney Dis 30:S96–101

    CAS  PubMed  Google Scholar 

  14. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930–936

    PubMed  Google Scholar 

  15. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT (1983) Hospital-acquired renal insufficiency: a prospective study. Am J Med 74:243–248

    CAS  PubMed  Google Scholar 

  16. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254–261

    CAS  PubMed  Google Scholar 

  17. Manske CL, Sprafka JM, Strony JT, Wang Y (1990) Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615–620

    CAS  PubMed  Google Scholar 

  18. Yoshioka T, Fogo A, Beckman JK (1992) Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008–1015

    CAS  PubMed  Google Scholar 

  19. McCarthy CS, Becker JA (1992) Multiple myeloma and contrast media. Radiology 183:519–521

    CAS  PubMed  Google Scholar 

  20. Rosenstock JL, Bruno R, Kim JK, Lubarsky L, Schaller R, Panagopoulos G, DeVita MV, Michelis MF (2008) The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol 40:749–755

    CAS  PubMed  Google Scholar 

  21. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, Moses JW, Leon MB, Dangas G (2005) Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67:706–713

    PubMed  Google Scholar 

  22. Ahuja TS, Niaz N, Agraharkar M (2000) Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 54:11–14

    CAS  PubMed  Google Scholar 

  23. Ranucci M, Ballotta A, Kunkl A, De Benedetti D, Kandil H, Conti D, Mollichelli N, Bossone E, Mehta RH (2008) Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol 101:1112–1118

    PubMed  Google Scholar 

  24. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O’Neill WW (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519

    PubMed  Google Scholar 

  25. Arakawa K, Suzuki H, Naitoh M, Matsumoto A, Hayashi K, Matsuda H, Ichihara A, Kubota E, Saruta T (1996) Role of adenosine in the renal responses to contrast medium. Kidney Int 49:1199–1206

    CAS  PubMed  Google Scholar 

  26. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C (1983) Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 18:160–166

    CAS  PubMed  Google Scholar 

  27. Seeliger E, Flemming B, Wronski T, Ladwig M, Arakelyan K, Godes M, Mockel M, Persson PB (2007) Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 18:2912–2920

    CAS  PubMed  Google Scholar 

  28. Weisberg LS, Kurnik PB, Kurnik BR (1992) Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 41:1408–1415

    CAS  PubMed  Google Scholar 

  29. Mockel M, Radovic M, Kuhnle Y, Combe V, Waigand J, Schroder S, Dietz R, Frei U, Eckardt KU (2008) Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 23:1588–1594

    PubMed  Google Scholar 

  30. Heyman SN, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 3:288–296

    PubMed  Google Scholar 

  31. Brezis M, Rosen S (1995) Hypoxia of the renal medulla—its implications for disease. N Engl J Med 332:647–655

    CAS  PubMed  Google Scholar 

  32. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M (1994) Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94:1069–1075

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S (1991) Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40:632–642

    CAS  PubMed  Google Scholar 

  34. Liss P, Nygren A, Erikson U, Ulfendahl HR (1998) Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 53:698–702

    CAS  PubMed  Google Scholar 

  35. Liss P, Carlsson PO, Palm F, Hansell P (2004) Adenosine A1 receptors in contrast media-induced renal dysfunction in the normal rat. Eur Radiol 14:1297–1302

    PubMed  Google Scholar 

  36. Agmon Y, Dinour D, Brezis M (1993) Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow. Am J Physiol 265:F802–806

    CAS  PubMed  Google Scholar 

  37. Kubo SH, Rector TS, Bank AJ (1996) Endothelial nitric oxide pathway function in the peripheral vasculature of patients with heart failure. J Card Fail 2:S217–223

    CAS  PubMed  Google Scholar 

  38. Zoccali C (2006) Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 17:S61–63

    PubMed  Google Scholar 

  39. Calver A, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548–2554

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Panza JA, Quyyumi AA, Callahan TS, Epstein SE (1993) Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 21:1145–1151

    CAS  PubMed  Google Scholar 

  41. Liss P, Carlsson PO, Nygren A, Palm F, Hansell P (2003) Et-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiol 44:111–117

    CAS  PubMed  Google Scholar 

  42. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH (1992) Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58–65

    CAS  PubMed  Google Scholar 

  43. Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44:248–252

    CAS  PubMed  Google Scholar 

  44. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, Siamopoulos KC, Tsakiris D (2006) Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48:752–760

    CAS  PubMed  Google Scholar 

  45. White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin MC, Racine N, He Y, Yao G, Rouleau JL, Schiffrin EL, Touyz RM (2006) Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond) 110:483–489

    CAS  Google Scholar 

  46. Hayden MR, Whaley-Connell A, Sowers JR (2005) Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. Am J Nephrol 25:553–569

    CAS  PubMed  Google Scholar 

  47. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr (1990) Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 258:F115–120

    CAS  PubMed  Google Scholar 

  48. Araujo M, Welch WJ (2006) Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 15:72–77

    CAS  PubMed  Google Scholar 

  49. Itoh Y, Yano T, Sendo T, Sueyasu M, Hirano K, Kanaide H, Oishi R (2006) Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. Kidney Int 69:288–297

    CAS  PubMed  Google Scholar 

  50. Schick CS, Haller C (1999) Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 14:342–347

    CAS  PubMed  Google Scholar 

  51. Peer A, Averbukh Z, Berman S, Modai D, Averbukh M, Weissgarten J (2003) Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, endothelial, and hepatic cells. Invest Radiol 38:177–182

    CAS  PubMed  Google Scholar 

  52. Haller C, Hizoh I (2004) The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 39:149–154

    CAS  PubMed  Google Scholar 

  53. Dobrota M, Powell CJ, Holtz E, Wallin A, Vik H (1995) Biochemical and morphological effects of contrast media on the kidney. Acta Radiol Suppl 399:196–203

    CAS  PubMed  Google Scholar 

  54. Ueda J, Nygren A, Hansell P, Erikson U (1992) Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Acta Radiol 33:596–599

    CAS  PubMed  Google Scholar 

  55. Ueda J, Nygren A, Hansell P, Ulfendahl HR (1993) Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 34:83–87

    CAS  PubMed  Google Scholar 

  56. Ueda J, Nygren A, Sjoquist M, Jacobsson E, Ulfendahl HR, Araki Y (1998) Iodine concentrations in the rat kidney measured by X-ray microanalysis. Comparison of concentrations and viscosities in the proximal tubules and renal pelvis after intravenous injections of contrast media. Acta Radiol 39:90–95

    CAS  PubMed  Google Scholar 

  57. Persson PB, Tepel M (2006) Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl 100:S8–10

    CAS  Google Scholar 

  58. Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD (2004) Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94:300–305

    PubMed  Google Scholar 

  59. Kane GC, Doyle BJ, Lerman A, Barsness GW, Best PJ, Rihal CS (2008) Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol 51:89–90

    PubMed  Google Scholar 

  60. Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL (2009) Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150:170–177

    PubMed  Google Scholar 

  61. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171–178

    CAS  PubMed  Google Scholar 

  62. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499

    CAS  PubMed  Google Scholar 

  63. McCullough PA, Bertrand ME, Brinker JA, Stacul F (2006) A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48:692–699

    CAS  PubMed  Google Scholar 

  64. Heinrich MC, Haberle L, Muller V, Bautz W, Uder M (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250:68–86

    PubMed  Google Scholar 

  65. Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41:815–821

    CAS  PubMed  Google Scholar 

  66. Kuhn MJ, Chen N, Sahani DV, Reimer D, van Beek EJ, Heiken JP, So GJ (2008) The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR Am J Roentgenol 191:151–157

    PubMed  Google Scholar 

  67. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336

    CAS  PubMed  Google Scholar 

  68. Solomon R, Werner C, Mann D, D’Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420

    CAS  PubMed  Google Scholar 

  69. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29–34

    CAS  PubMed  Google Scholar 

  70. Weisbord SD, Bruns FJ, Saul MI, Palevsky PM (2004) Provider use of preventive strategies for radiocontrast nephropathy in high-risk patients. Nephron Clin Pract 96:c56–62

    PubMed  Google Scholar 

  71. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328–2334

    CAS  PubMed  Google Scholar 

  72. Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M (2007) Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 100:781–786

    CAS  PubMed  Google Scholar 

  73. Hogan SE, L’Allier P, Chetcuti S, Grossman PM, Nallamothu BK, Duvernoy C, Bates E, Moscucci M, Gurm HS (2008) Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 156:414–421

    CAS  PubMed  Google Scholar 

  74. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F (2008) Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52:599–604

    CAS  PubMed  Google Scholar 

  75. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS (2008) Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol 3:10–18

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184

    CAS  PubMed  Google Scholar 

  77. Efrati S, Dishy V, Averbukh M, Blatt A, Krakover R, Weisgarten J, Morrow JD, Stein MC, Golik A (2003) The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int 64:2182–2187

    CAS  PubMed  Google Scholar 

  78. Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Lombardi M, Sagripanti S, Buratti S, Ardissino D, Cabassi A (2004) Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media. Nephrol Dial Transplant 19:865–869

    CAS  PubMed  Google Scholar 

  79. Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC (2004) Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 19:1803–1807

    CAS  PubMed  Google Scholar 

  80. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289:553–558

    CAS  PubMed  Google Scholar 

  81. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354:2773–2782

    CAS  PubMed  Google Scholar 

  82. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41:2114–2118

    PubMed  Google Scholar 

  83. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407–410

    CAS  PubMed  Google Scholar 

  84. Bagshaw SM, McAlister FA, Manns BJ, Ghali WA (2006) Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med 166:161–166

    CAS  PubMed  Google Scholar 

  85. Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER (2004) Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117:938–947

    CAS  PubMed  Google Scholar 

  86. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148:284–294

    PubMed  Google Scholar 

  87. Fishbane S (2008) N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 3:281–287

    CAS  PubMed  Google Scholar 

  88. Vaitkus PT, Brar C (2007) N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. Am Heart J 153:275–280

    CAS  PubMed  Google Scholar 

  89. Kanter MZ (2006) Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 63:1821–1827

    CAS  PubMed  Google Scholar 

  90. Katholi RE, Taylor GJ, McCann WP, Woods WT Jr, Womack KA, McCoy CD, Katholi CR, Moses HW, Mishkel GJ, Lucore CL, Holloway RM, Miller BD, Woodruff RC, Dove JT, Mikell FL, Schneider JA (1995) Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 195:17–22

    CAS  PubMed  Google Scholar 

  91. Shammas NW, Kapalis MJ, Harris M, McKinney D, Coyne EP (2001) Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. J Invasive Cardiol 13:738–740

    CAS  PubMed  Google Scholar 

  92. Bagshaw SM, Ghali WA (2005) Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch Intern Med 165:1087–1093

    PubMed  Google Scholar 

  93. Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining A, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM (2006) Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology 239:793–804

    PubMed  Google Scholar 

  94. Gurkowski L, MacDougall M, Wiegmann T (1995) Effects of misoprostol on contrast-induced renal dysfunction. Am J Ther 2:837–842

    PubMed  Google Scholar 

  95. Koch JA, Plum J, Grabensee B, Modder U (2000) Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant 15:43–49

    CAS  PubMed  Google Scholar 

  96. Sketch MH Jr, Whelton A, Schollmayer E, Koch JA, Bernink PJ, Woltering F, Brinker J (2001) Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study. Am J Ther 8:155–162

    PubMed  Google Scholar 

  97. Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837–2842

    CAS  PubMed  Google Scholar 

  98. Briguori C, Airoldi F, D’Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211–1217

    CAS  PubMed  Google Scholar 

  99. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK (2002) Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57:279–283

    PubMed  Google Scholar 

  100. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O’Neill WW (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284–2291

    CAS  PubMed  Google Scholar 

  101. Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J (1998) Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 64:432–436

    CAS  PubMed  Google Scholar 

  102. Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB (1999) Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 83(260–263):A265

    Google Scholar 

  103. Weisberg LS, Kurnik PB, Kurnik BR (1994) Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259–265

    CAS  PubMed  Google Scholar 

  104. Gare M, Haviv YS, Ben-Yehuda A, Rubinger D, Bdolah-Abram T, Fuchs S, Gat O, Popovtzer MM, Gotsman MS, Mosseri M (1999) The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 34:1682–1688

    CAS  PubMed  Google Scholar 

  105. Cacoub P, Deray G, Baumelou A, Jacobs C (1988) No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. Clin Nephrol 29:215–216

    CAS  PubMed  Google Scholar 

  106. Russo D, Testa A, Della Volpe L, Sansone G (1990) Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 55:254–257

    CAS  PubMed  Google Scholar 

  107. Carraro M, Mancini W, Artero M, Stacul F, Grotto M, Cova M, Faccini L (1996) Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transplant 11:444–448

    CAS  PubMed  Google Scholar 

  108. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31:674–680

    CAS  PubMed  Google Scholar 

  109. Miller HI, Dascalu A, Rassin TA, Wollman Y, Chernichowsky T, Iaina A (2003) Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial. Am J Nephrol 23:91–95

    CAS  PubMed  Google Scholar 

  110. Attallah N, Yassine L, Musial J, Yee J, Fisher K (2004) The potential role of statins in contrast nephropathy. Clin Nephrol 62:273–278

    CAS  PubMed  Google Scholar 

  111. Khanal S, Attallah N, Smith DE, Kline-Rogers E, Share D, O’Donnell MJ, Moscucci M (2005) Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 118:843–849

    CAS  PubMed  Google Scholar 

  112. Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, Youn TJ, Chung WY, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS (2008) Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial–a randomized controlled study. Am Heart J 155:e491–498

    Google Scholar 

  113. Weinstein JM, Heyman S, Brezis M (1992) Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413–415

    CAS  PubMed  Google Scholar 

  114. Anto HR, Chou SY, Porush JG, Shapiro WB (1981) Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 141:1652–1656

    CAS  PubMed  Google Scholar 

  115. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ (2000) Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675–1680

    CAS  PubMed  Google Scholar 

  116. Schindler R, Stahl C, Venz S, Ludat K, Krause W, Frei U (2001) Removal of contrast media by different extracorporeal treatments. Nephrol Dial Transplant 16:1471–1474

    CAS  PubMed  Google Scholar 

  117. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P (1998) Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358–362

    CAS  PubMed  Google Scholar 

  118. Sterner G, Frennby B, Kurkus J, Nyman U (2000) Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy? Scand J Urol Nephrol 34:323–326

    CAS  PubMed  Google Scholar 

  119. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692–698

    CAS  PubMed  Google Scholar 

  120. Frank H, Werner D, Lorusso V, Klinghammer L, Daniel WG, Kunzendorf U, Ludwig J (2003) Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 60:176–182

    CAS  PubMed  Google Scholar 

  121. Lee PT, Chou KJ, Liu CP, Mar GY, Chen CL, Hsu CY, Fang HC, Chung HM (2007) Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol 50:1015–1020

    PubMed  Google Scholar 

  122. Gabutti L, Marone C, Monti M, Malfanti M, Zwahlen U, Pasotti E, Colucci G, Schonholzer C (2003) Does continuous venovenous hemodiafiltration concomitant with radiological procedures provide a significant and safe removal of the iodinated contrast ioversol? Blood Purif 21:152–157

    CAS  PubMed  Google Scholar 

  123. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349:1333–1340

    CAS  PubMed  Google Scholar 

  124. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, Grazi M, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL (2006) Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 119:155–162

    PubMed  Google Scholar 

  125. Klarenbach SW, Pannu N, Tonelli MA, Manns BJ (2006) Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease. Crit Care Med 34:1044–1051

    PubMed  Google Scholar 

  126. Younathan CM, Kaude JV, Cook MD, Shaw GS, Peterson JC (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. AJR Am J Roentgenol 163:969–971

    CAS  PubMed  Google Scholar 

  127. Hamani A, Petitclerc T, Jacobs C, Deray G (1998) Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis? Nephrol Dial Transplant 13:1051–1052

    CAS  PubMed  Google Scholar 

  128. Morcos SK, Thomsen HS, Webb JA (2002) Dialysis and contrast media. Eur Radiol 12:3026–3030

    PubMed  Google Scholar 

  129. Sam AD 2nd, Morasch MD, Collins J, Song G, Chen R, Pereles FS (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313–318

    PubMed  Google Scholar 

  130. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311–318 discussion 328-329

    PubMed  Google Scholar 

  131. Thomsen HS (2005) How to avoid CIN: guidelines from the European Society of Urogenital Radiology. Nephrol Dial Transplant 20[Suppl 1]:i18–22

    PubMed  Google Scholar 

  132. Medwatch F (2006) Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Ominiscan, OptiMARK, Magnevist, ProHance, and MultiHance. Available at: https://doi.org/FDA.GOV/medwatch/safety/2006/safety06.htm

  133. Grobner T (2006) Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108

    CAS  PubMed  Google Scholar 

  134. Boyd AS, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56:27–30

    PubMed  Google Scholar 

  135. Penfield JG, Reilly RF (2008) Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents? Semin Dial 21:129–134

    PubMed  Google Scholar 

  136. Solomon R, Deray G (2006) How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl 69[Suppl S100]:S51–S53

  137. Goldfarb S, McCullough PA, McDermott J, Gay SB (2009) Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 84:170–179

    PubMed  PubMed Central  Google Scholar 

  138. Arend LJ, Bakris GL, Burnett JC Jr, Megerian C, Spielman WS (1987) Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 110:406–411

    CAS  PubMed  Google Scholar 

  139. Erley C (2006) Concomitant drugs with exposure to contrast media. Kidney Int Suppl 69:S20–S24

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Southwestern Medical Center, Dallas, TX, USA

    Robert E. Cronin

  2. VA North Texas Health Care System (111), 4500 S. Lancaster Road, Dallas, TX, 75216, USA

    Robert E. Cronin

Authors
  1. Robert E. Cronin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert E. Cronin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cronin, R.E. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol 25, 191–204 (2010). https://doi.org/10.1007/s00467-009-1204-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-009-1204-z

Keywords

Search

Navigation